PWA
BBP icon

Portus Wealth Advisors’s Virtus Biotech ETF BBP Stock Holding History

Portus Wealth Advisors’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58
Closed -$4.82K – 99
2026
Q1 		$4.82K Buy
+58
New +$4.77K ﹤0.01% 177

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Portus Wealth Advisors's BBP Position: Q2 2026 in Review

Portus Wealth Advisors sold out of Virtus Biotech ETF (BBP) in Q2 2026, closing a stake of 58 shares — an estimated $4.82K sold.

Portus Wealth Advisors first reported a position in BBP in Q1 2026 and held it in 1 quarter. The position peaked at $4.82K in Q1 2026. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Portus Wealth Advisors reported no remaining Virtus Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Portus Wealth Advisors sold 58 Virtus Biotech ETF shares in Q2 2026, an estimated $4.82K.
  • Portus Wealth Advisors first reported a position in Virtus Biotech ETF in Q1 2026 and held it in 1 quarter.
  • Portus Wealth Advisors's Virtus Biotech ETF position peaked at $4.82K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Portus Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.